Currently, the ε4 allele of APOE (APOE-ε4) is considered the strongest genetic risk factor for autosomal dominant early-onset AD and late-onset AD in a dose-dependent manner [23], but it was also found to be associated with DLB in GWAS [24]. Here, APOE is linked to Onset.